IPath Series Valuation Analysis

ETFs . USA . 
ETF . iPath Series B
VXZ ETF  USD 55.95  0.46  0.83%   
IPath Series is priced without meaningful earnings support, reflecting the current earnings and balance-sheet profile.
Above Model Estimate
Today
55.95
For iPath Series B, valuation is derived from the weighted behavior of its portfolio constituents over a 3 months horizon. Pricing gaps often arise from short-term dislocations between fund value and underlying asset movements.
50.43
Downside
51.86
Intrinsic Value
61.55
Upside
Current intrinsic value estimate framed by downside and upside probability thresholds.
Target Odds

What This Indicates

Available data for IPath Series provides a starting point for valuation analysis, though additional context from operating trends and sector dynamics may be needed for a more complete picture.

Combined Signal Overview

The financial profile frames iPath Series B as a business currently operating below profitability breakeven in the Milleis Investissements Funds sector. At current levels, IPath Series's valuation reflects an earnings profile that has not yet stabilized. A re-rating would require demonstrated improvement in profitability and cost discipline.
The analysis above provides a structured baseline for iPath Series B that becomes more informative as new data arrives. For funds and ETFs, valuation reflects the behavior of underlying holdings, making asset allocation and sector exposure the primary drivers.

Valuation Framework, Methodology & Assumptions

IPath Series is an ETF with exposure aligned to Absolute Returns ETFs, Volatility ETFs. Valuation context is typically interpreted through NAV, premium/discount behavior, and tracking difference. Certain defensive traits may reduce sensitivity to broader macroeconomic fluctuations.

iPath Series B analytics rely on fund disclosures and market reference feeds, with quality checks and normalization applied. Valuation outputs are model-derived and depend on published assumptions and reference inputs.

The analysis above is generated by quantitative models and is provided for informational and educational purposes only. It does not constitute financial advice, investment recommendations, or an endorsement to buy or sell any security. All investing involves risk, including the possible loss of principal. Consult a qualified financial advisor before making investment decisions. See our Terms of Use for full details.

Financial data referenced in this analysis is derived from publicly available SEC filings, audited financial statements, and third-party market data providers. The intrinsic value estimate is generated by Macroaxis quantitative models that incorporate fundamental analysis, technical indicators, and risk metrics.

The methodology combines multiple analytical inputs:

  • Fundamental analysis - financial statements, profitability ratios, debt structure, and cash flow metrics sourced from SEC filings and public financial reports
  • Technical indicators - historical price patterns, momentum signals, and volatility measures
  • Risk assessment - probability of bankruptcy models, market risk metrics, and downside scenario analysis
  • Peer comparison - relative valuation against industry peers using standardized multiples

Model outputs are refreshed periodically as new financial data becomes available. Past model performance is not indicative of future results. The intrinsic value estimate reflects a point-in-time calculation and should be considered alongside other research and professional advice.

Data sourced from SEC filings (EDGAR), public financial statements, and market data providers.

Editorial review and methodology oversight provided by: Ellen Johnson, Member of Macroaxis Editorial Board

More Resources for IPath Series ETF Analysis

iPath Series B can be assessed through both market price and NAV, which can tell different stories during volatile periods.
Profitability
Analysis
Details
Buy or Sell
Analysis
Details
Technical
Analysis
Details
IPath Series market price and NAV can differ because they are formed through different mechanisms. Assessment often reviews fund costs, underlying exposure, category peers, and benchmark tracking precision.
Tools
Analysis
Directory
Company
2026 Macroaxis LLC Made with in San Francisco
Privacy Terms Widgets Feedback
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and conditions page.